According to WuXi Biologics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.60. At the end of 2024 the company had a P/S ratio of 3.61.
Year | P/S ratio | Change |
---|---|---|
2024 | 3.61 | -45.06% |
2023 | 6.56 | -55.22% |
2022 | 14.7 | -52.79% |
2021 | 31.0 | -50.26% |
2020 | 62.4 | 117.09% |
2019 | 28.8 | 34.99% |
2018 | 21.3 | -18.48% |
2017 | 26.1 |